Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay

American Journal of Nephrology

Volumn 18, Issue 5, 1998, Pages 373-378

  Yang, Chul Woo ^a   Kim, Young Ok ^a   Kim, Yong Soo ^a   Kim, Suk Young ^a   Moon, In Sung ^b   Ahn, Hee Jong ^b   Koh, Yong Bok ^b   Bang, Byung Kee ^a,b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Antigenemia assay; Cytomegalovirus; Ganciclovir; OKT3; Renal transplant recipients

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIREMIA; VIRUS DETECTION;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PROSPECTIVE STUDIES; VIREMIA;

EID: 0031693056     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013379     Document Type: Article

References (21)

1. Fryd DS, Peterson DK, Ferguson RM, Simmons RL, Balfour HH Jr, Najarian JS: Cytomegalovirus as a risk factor in renal transplantation. Transplantation 1980;30:436-439.
2. Rubin RH: Infectious disease complications of renal transplantation. Kidney Int 1993;44: 221-226.
3. Betts RF, Freeman RB, Douglas RII Jr, Talley TE, Rundell B: Transmission of cytomegalovirus infection with renal allograft. Kidney Int 1975,8:385-392.
4. Rubin RH: Clinical approach to infection in the compromised host; in Rubin RH, Young LS (eds): Infection in the Organ Transplant Recipient. New York, Plenum Press, 1994, pp 629-705.
5. Tolkoff-Rubin NE, Rubin RH: Clinical approach to viral and fungal infections in the renal transplant patient. Semin Nephrol 1992; 12:364-375.
6. Schmidt GM, Horack DA, Niland JC, Duncan SR, Forman SJ, Zaja JA, the City of Hope Stanford-Synthex CMV Study Group: A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991;324:1005-1011.
7. Martin M, Manez R, Linden P, Estores D, Torre-Cisneros J, Kusne S, Ondick L, Ptachanski R, Irish W, Kisor D, Felser I, Rinaldo C, Stieber A, Fung J, Ho M, Simmons R, Starzl T: A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1994;58:779-785.
8. Dum DL, Gillinghan KJ, Kramer MA, Schmidt WJ, Erice E, Balfour HH Jr, Goses PF, Gruessner RWJ, Matas JS: A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation 1994;57: 876-884.
9. Rondeau E, Bourgeon B, Peraldi MN, Lang P, Bussen C, Schulte KM, Weill B, Sraer JD: Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant 1993;8:858-862.
10. Conti DJ, Freed BM, Gruber SA, Lempert N: Prophylaxis of primary cytomegalovirus disease in renal transplant recipients: A trial of ganciclovir vs. immunoglobulin. Arch Surg 1994;129:443-447.
11. Gómez E, de Oña M, Aguado S, Tejada F, Nuñez M, Portal C, Diaz-Corte C, Sanchez E, Ortega F, Alvarez-Grande J: Cytomegalovirus preemptive therapy, with ganciclovir in renal transplant patients treated with OKT3. Nephron 1996;74:367-372.
12. The TH, van der Ploeg M, van den Berg AP, Vilieger AM, van der Giessen M, van Son WJ: Direct detection of cytomegalovirus in peripheral blood leukocytes: A review of the antigenemia assay and polymerase chain reaction. Transplantation 1992;54:193-198.
13. Murray BM, Brentjens J, Amsterdam D, Myers J, Gray V, Pawlowski I, Schwegler K, Singh JP, Venuto RC: The cytomegalovirus-antigenemia assay in the diagnosis of posttransplant cytomegalovirus infection. J Am Soc Nephrol 1994; 4:1615-1622.
14. van den Berg AP, van der Bij W, van Son WJ: Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation: A report of 130 consecutive patients. Transplantation 1989;48: 991-995.
15. van den Berg AP, van Son WJ, van der Bij W, van der Giessen M, The TH: Early identification of patients at high risk of severe cytomegalovirus disease after renal transplantation using the immediate-early antigenemia assay. Transplant Proc 1990;22:1800-1802.
16. Peiris JSM, Taylor CE, Main J, Graham K, Madeley CR: Diagnosis of cytomegalovirus (CMV) disease in renal allograft recipient: The role of semiquantitative polymerase chain reaction (PCR). Nephrol Dial Transplant 1995; 10:1198-2205.
17. Wie SH, Song HC, Kim YR, Yoo SA, Lee SH, Yang CW, Kim YS, Kim SY, Kang MW, Bang BK: Immunocytochemical assay for cytomegalovirus detection in peripheral blood for renal transplant patients in clinical practice. Transplant Proc 1996;28:1505-1506.
18. Yoon YS, Jin DC, Yang CW, Kim SY, Bang BK, Kim WI, Koh YB: The effect of HLA mismatching on graft survival in living-donor kidney transplants. Catholic Medical Center, 1984 to 1993. Clin Transplant 1993:275-283.
19. Solez K, Axelsen RA, Benediktsson H, et al: International standardization of criteria for the histology diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-422.
20. Halwachs G, Zach R, Pogglitsch H, Holzer H, Tirai A, Iberer F, Wasler A, Tscheliessnigg HP, Lanzer G, Folsch B, Wilders-Truschnig M: A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice. Transplantation 1993;56:338-342.
21. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, Schooley RT, Isaacson D, Doran M, Delvecchio A, Delmonico FL, Auchincloss H Jr, Rubin RH: Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992;53:68-72.